Efficacy of Online CBT for Adolescent Anxiety and Depression Comorbidity on Symptom Severity: A Randomised Controlled Trial of the Momentum Program

Griffith University0 个研究点目标入组 270 人开始时间: 2022年10月28日最近更新: 2024年7月8日

适应症

试验速览

暂无简介。

•Following registration and the initial assessment process that is part of the open access Momentum Platform, adolescents aged 13-17 years who are found to demonstrate comorbid anxiety and depression symptoms will be invited to participate in the study. Participants must be willing to participate in either of the two conditions (COM or PRI).

•Potential participants will be excluded if the adolescent (i) has an intellectual or a developmental disorder (autism, developmental delay); (ii) is receiving other psychological/psychiatric treatment for their primary problem (anxiety or depression); (iii) is not stabilised on a medication prior to enrolment into this study or alters their medication dosage during the trial (if the participant is using medication for anxiety or depression); (iv) displays a high suicidal risk (i.e., a score >21 on the Suicidal Ideation Attributes Scale by Van Spijker et al. (2014)).

发起方